Evidence map›Paper›PMID 39520690›Full record

Observational studyNeuropsychopharmacology reports2025

Effects of repetitive transcranial magnetic stimulation therapy on weight and lipid metabolism in patients with treatment-resistant depression: A preliminary single-center retrospective cohort study.

Ami Nakazawa, Yuki Matsuda, Ryuichi Yamazaki, Nanase Taruishi, Shinsuke Kito

Abstract readObservational Study
In one paragraph

Observational study in Neuropsychopharmacology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ami NakazawaDepartment of Psychiatry, Jikei University School of Medicine, Minato-ku, Tokyo, Japan.ORCID https://orcid.org/0009-0001-7274-1639
Yuki MatsudaDepartment of Psychiatry, Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Ryuichi YamazakiDepartment of Psychiatry, Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Nanase TaruishiDepartment of Psychiatry, Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
Shinsuke KitoDepartment of Psychiatry, Jikei University School of Medicine, Minato-ku, Tokyo, Japan.

Funding

The Jikei University School of Medicine Women's Researcher Career Support System
6 · The paper itself

Abstract

aimThis study aimed to elucidate the effects of repetitive transcranial magnetic stimulation (rTMS) on weight, body mass index (BMI), and lipid metabolism in patients with treatment-resistant depression (TRD).

methodsThis retrospective observational study included patients with TRD who received rTMS treatment at the Jikei University Hospital from September 2018 to August 2021. The patients were diagnosed based on the DSM-5 and ICD-10 criteria and treated using the NeuroStar TMS System. For 3-6 weeks, 10-Hz rTMS was administered to the left dorsolateral prefrontal cortex at 120% motor threshold. The primary outcomes were changes in weight and BMI, whereas the secondary outcomes included changes in total, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) cholesterol levels, thyroid function indicators, as well as HAMD-17, HAMD-24, and Montgomery-Åsberg Depression Rating Scale (MADRS) scores. Statistical analysis was conducted using paired t-tests and repeated measures ANOVA.

resultsAmong the 34 patients (20 men and 14 women) included, no significant changes were observed in weight or BMI after rTMS treatment (average weight reduction: -0.50 kg, 95% CI: -0.14 to 0.56, p = 0.24; average BMI reduction: -0.21, 95% CI: -0.10 to 0.61, p = 0.15). However, significant reductions in total, HDL, and LDL cholesterol levels and FT4 were observed. Furthermore, the HAMD-17, HAMD-24, and MADRS scores significantly increased post-treatment.

conclusionrTMS treatment did not affect weight or BMI in patients with TRD but is believed to improve lipid metabolism.

Indexed as

Body Mass IndexDepressive Disorder, Treatment-ResistantLipid MetabolismTranscranial Magnetic StimulationAdultAgedBody WeightDorsolateral Prefrontal CortexFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment Outcomelipid metabolismrepetitive transcranial magnetic stimulationtreatment‐resistant depressionweight

Identifiers

PMID39520690
PMCPMC11660761

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.